Holen Sie sich die Stockscreener-App
73.57
0.93%
-0.69
Handel nachbörslich:
73.57
Mirum Pharmaceuticals Inc Aktie (MIRM) Neueste Nachrichten
Mirum stock is a new Buy at TD Cowen (MIRM:NASDAQ) - Seeking Alpha
TD Cowen initiates coverage on Mirum Pharmaceuticals stock with Buy rating - Investing.com
CRMD vs. MIRM: Which Specialized Biotech Stock is the Better Pick? - sharewise.com
Contravisory Investment Management Inc. Acquires Shares of 5,307 Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Loss-Making Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Expected To Breakeven In The Medium-Term - Yahoo
Atle Fund Management AB Grows Holdings in Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
12,200 Shares in Mirum Pharmaceuticals, Inc. $MIRM Bought by Strs Ohio - MarketBeat
Gainers Report: What are Mirum Pharmaceuticals Inc.’s earnings expectationsJuly 2025 Trade Ideas & Safe Entry Momentum Stock Tips - خودرو بانک
Earnings Recap: Should I hold or sell Mirum Pharmaceuticals Inc nowPortfolio Update Summary & Fast Momentum Stock Entry Tips - khodrobank.com
Bond Watch: What is Mirum Pharmaceuticals Inc. s debt to equity ratioMarket Growth Summary & Pattern Based Trade Signal System - khodrobank.com
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Receives $74.44 Consensus Target Price from Brokerages - MarketBeat
Investment Recap: Is Mirum Pharmaceuticals Inc impacted by rising ratesProduct Launch & Technical Pattern Alert System - خودرو بانک
Retail Trends: Is Springview Holdings Ltd showing insider buyingTrade Entry Report & Expert-Curated Trade Recommendations - خودرو بانک
Mirum Pharmaceuticals, Inc. $MIRM Shares Sold by Millennium Management LLC - MarketBeat
Risk Report: Will Mirum Pharmaceuticals Inc benefit from AI trends2025 Market Overview & Precise Swing Trade Alerts - خودرو بانک
Citizens JMP Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $81 - 富途牛牛
H.C. Wainwright Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $80 - 富途牛牛
Citizens JMP reiterates Market Outperform rating on Mirum Pharmaceuticals stock - Investing.com Canada
Mirum Pharmaceuticals, Inc. $MIRM Shares Bought by Rhumbline Advisers - Defense World
JPMorgan Chase & Co. Issues Positive Forecast for Mirum Pharmaceuticals (NASDAQ:MIRM) Stock Price - MarketBeat
Activity Recap: Is Mirum Pharmaceuticals Inc impacted by rising ratesJuly 2025 Closing Moves & Consistent Return Investment Signals - خودرو بانک
Trade Report: Can Mirum Pharmaceuticals Inc. deliver consistent dividendsMarket Volume Summary & Free Community Consensus Stock Picks - خودرو بانک
Mirum Pharmaceuticals, Inc. $MIRM Holdings Increased by Woodline Partners LP - MarketBeat
Mirum Pharmaceuticals (NASDAQ:MIRM) Reaches New 1-Year HighTime to Buy? - MarketBeat
Mirum Pharmaceuticals Announces Enrollment Completion in the Phase 2b VISTAS Study - Investing News Network
Mirum Pharma director Brege sells $1.26m in shares - Investing.com India
Mirum Pharma director Brege sells $1.26m in shares By Investing.com - Investing.com Canada
J.P. Morgan Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Raises Target Price to $77 - 富途牛牛
Adage Capital Partners GP L.L.C. Purchases 195,000 Shares of Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Saira Ramasastry, Mirum director, sells $1.3m in shares By Investing.com - Investing.com Canada
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Mirum Pharmaceuticals (NASDAQ:MIRM) Sets New 52-Week HighHere's Why - MarketBeat
Eventide Asset Management LLC Sells 79,938 Shares of Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Mirum Pharmaceuticals at Morgan Stanley Conference: Strategic Growth Insights By Investing.com - Investing.com Canada
Mirum Pharmaceuticals announces enrollment completion in the phase 2b Vistas study - MarketScreener
Published on: 2025-09-08 12:42:47 - beatles.ru
Northern Trust Corp Decreases Holdings in Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Multi factor analysis applied to Mirum Pharmaceuticals Inc.Weekly Investment Report & Stock Portfolio Risk Management - Newser
Is Mirum Pharmaceuticals Inc. stock overvalued or fairly priced2025 Geopolitical Influence & Short-Term High Return Ideas - خودرو بانک
PDT Partners LLC Has $6.19 Million Stock Holdings in Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Is Mirum Pharmaceuticals Inc. forming bullish engulfing patternsEarnings Trend Report & Safe Entry Trade Signal Reports - خودرو بانک
Can Mirum Pharmaceuticals Inc. reach resistance levels soon2025 EndofYear Setup & Fast Gain Swing Alerts - خودرو بانک
Real time scanner hits for Mirum Pharmaceuticals Inc. explainedBond Market & AI Driven Stock Movement Reports - Newser
Sentiment analysis tools applied to Mirum Pharmaceuticals Inc.2025 Market Trends & Fast Entry Momentum Trade Alerts - Newser
Is Mirum Pharmaceuticals Inc. forming a reversal patternPortfolio Growth Summary & Weekly Top Gainers Trade List - Newser
Published on: 2025-09-05 14:03:50 - Newser
Signal strength of Mirum Pharmaceuticals Inc. stock in tech scannersQuarterly Risk Review & Safe Capital Growth Stock Tips - Newser
Chart overlay techniques for tracking Mirum Pharmaceuticals Inc.Earnings Performance Report & Capital Efficiency Focused Ideas - Newser
Rafferty Asset Management LLC Raises Holdings in Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Will Mirum Pharmaceuticals Inc. stock recover after recent dropMarket Movement Recap & Detailed Earnings Play Alerts - Newser
2.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):